A²I™
Pharma
Device
Home
Therapy Areas
Oncology
Rare Disease
Immunology
Neurology
Diabetes
Respiratory
Mental Health
Cardiovascular
Query
Equity
Request Access
A²I™ · Decision Corpus
PTAC Corpus
ⓘ
160 decisions
▼
—
Total Decisions
—
Recommended
—
High Access Risk
—
Equity Evidence Absent
⌕
All outcomes
Recommended
Not Recommended
Conditional
Deferred
All therapy areas
Oncology
Rare Disease
Immunology
Neurology
Diabetes
Respiratory
Mental Health
Cardiovascular
Other
All years
2020
2021
2022
2023
2024
2025
CE concern
Surrogate EP
Surrogate: yes
Surrogate: no
Comparator
placebo
active funded
active unfunded
none
mixed
unclear
Resub #
0 (first)
1
2+
Equity pop.
Maori
Pacific
Māori & Pacific
Other
None
Loading…